298 related articles for article (PubMed ID: 9918566)
1. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.
Hoernlein RF; Orlikowsky T; Zehrer C; Niethammer D; Sailer ER; Simmet T; Dannecker GE; Ammon HP
J Pharmacol Exp Ther; 1999 Feb; 288(2):613-9. PubMed ID: 9918566
[TBL] [Abstract][Full Text] [Related]
2. A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition.
Chashoo G; Singh SK; Sharma PR; Mondhe DM; Hamid A; Saxena A; Andotra SS; Shah BA; Qazi NA; Taneja SC; Saxena AK
Chem Biol Interact; 2011 Jan; 189(1-2):60-71. PubMed ID: 21056033
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells.
Park YS; Lee JH; Bondar J; Harwalkar JA; Safayhi H; Golubic M
Planta Med; 2002 May; 68(5):397-401. PubMed ID: 12058313
[TBL] [Abstract][Full Text] [Related]
4. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro.
Hostanska K; Daum G; Saller R
Anticancer Res; 2002; 22(5):2853-62. PubMed ID: 12530009
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
Safayhi H; Sailer ER; Ammon HP
Mol Pharmacol; 1995 Jun; 47(6):1212-6. PubMed ID: 7603462
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the antitumor effect of 11-keto-β-boswellic acid by its 3-α-hexanoyloxy derivative.
Chashoo G; Singh SK; Mondhe DM; Sharma PR; Andotra SS; Shah BA; Taneja SC; Saxena AK
Eur J Pharmacol; 2011 Oct; 668(3):390-400. PubMed ID: 21821018
[TBL] [Abstract][Full Text] [Related]
7. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling.
Sailer ER; Schweizer S; Boden SE; Ammon HP; Safayhi H
Eur J Biochem; 1998 Sep; 256(2):364-8. PubMed ID: 9760176
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture.
Shao Y; Ho CT; Chin CK; Badmaev V; Ma W; Huang MT
Planta Med; 1998 May; 64(4):328-31. PubMed ID: 9619114
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2.
Park YS; Lee JH; Harwalkar JA; Bondar J; Safayhi H; Golubic M
Adv Exp Med Biol; 2002; 507():387-93. PubMed ID: 12664615
[TBL] [Abstract][Full Text] [Related]
11. Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha.
Herzog CE; Holmes KA; Tuschong LM; Ganapathi R; Zwelling LA
Cancer Res; 1998 Dec; 58(23):5298-300. PubMed ID: 9850052
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.
Sailer ER; Subramanian LR; Rall B; Hoernlein RF; Ammon HP; Safayhi H
Br J Pharmacol; 1996 Feb; 117(4):615-8. PubMed ID: 8646405
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid.
Bishnoi M; Patil CS; Kumar A; Kulkarni SK
Indian J Exp Biol; 2006 Feb; 44(2):128-32. PubMed ID: 16480179
[TBL] [Abstract][Full Text] [Related]
14. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway.
Liu JJ; Nilsson A; Oredsson S; Badmaev V; Duan RD
Int J Mol Med; 2002 Oct; 10(4):501-5. PubMed ID: 12239601
[TBL] [Abstract][Full Text] [Related]
15. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
[TBL] [Abstract][Full Text] [Related]
16. [Effect of acetyl-11-keto-β-boswellic acid on proliferation, apoptosis and cell cycle of human acute myeloid leukemia cell line HL-60].
Yuan XY; Li YH; Qi ZH; Peng MY; Wan Z; Wang GP; Chen FP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1440-4. PubMed ID: 21176347
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by boswellic acids of human leukocyte elastase.
Safayhi H; Rall B; Sailer ER; Ammon HP
J Pharmacol Exp Ther; 1997 Apr; 281(1):460-3. PubMed ID: 9103531
[TBL] [Abstract][Full Text] [Related]
18. [Saikosaponin-d up-regulates GR mRNA expression and induces apoptosis in HL-60 cells].
Bu S; Xu J; Sun J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):354-6. PubMed ID: 11721431
[TBL] [Abstract][Full Text] [Related]
19. (-)-Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells.
Lin JP; Lu HF; Lee JH; Lin JG; Hsia TC; Wu LT; Chung JG
Anticancer Res; 2005; 25(3B):2069-74. PubMed ID: 16158947
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor mechanism of 3-bromopropionylamino benzoylurea on leukemia and lymphoma].
Li JN; Song DQ; Jiang JD
Yao Xue Xue Bao; 2004 Jul; 39(7):491-5. PubMed ID: 15493834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
